The PROTEMBO Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The goal of this prospective, multi-center, randomized, controlled study is to compare the safety and efficacy of the ProtEmbo Cerebral Embolic Protection device to a hybrid control (no embolic protection device (\'No Device\') and the Sentinel device) in subjects with severe symptomatic native aortic valve stenosis indicated undergoing a TAVR procedure.
Epistemonikos ID: f647ffef5c670c8f965b7f09eba0fc43ecb49963
First added on: May 15, 2024